Clinical meaning
D-dimer is a fibrin degradation product (FDP) — a small protein fragment released into the blood when a cross-linked fibrin clot is broken down by plasmin during fibrinolysis. Understanding D-dimer requires knowledge of the coagulation and fibrinolytic cascades. When the coagulation cascade is activated (by tissue injury, endothelial damage, or pathological thrombosis), thrombin converts fibrinogen to fibrin monomers, which polymerize into fibrin strands. Factor XIIIa (transglutaminase) then cross-links adjacent fibrin D-domains, creating a stable clot. When the fibrinolytic system is activated, plasminogen is converted to plasmin by tissue plasminogen activator (tPA). Plasmin cleaves cross-linked fibrin at specific sites, releasing D-dimer fragments into the circulation. Because D-dimer specifically comes from cross-linked fibrin (not fibrinogen), its presence indicates that both thrombin generation (clot formation) AND plasmin generation (clot breakdown) have occurred. D-dimer is a highly sensitive but poorly specific marker for thromboembolism. It has high negative predictive value — a normal D-dimer in a low-to-moderate pre-test probability patient effectively excludes VTE. However, D-dimer is elevated in many conditions: infection, inflammation, malignancy, pregnancy, post-surgical states, trauma, liver disease, DIC, and advanced age. This...